Correction: Effectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter clinical study.

PLoS One

Published: May 2024

The text refers to a correction made to a previously published article identified by the DOI 10.1371/journal.pone.0271907.
This correction is likely meant to address errors or omissions found in the original publication.
Such corrections are important for maintaining the accuracy and integrity of scientific literature.

[This corrects the article DOI: 10.1371/journal.pone.0271907.].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11081279	PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0303720	PLOS

Publication Analysis

correction effectiveness

effectiveness safety

safety weekly

weekly paclitaxel

paclitaxel cetuximab

cetuximab salvage

salvage chemotherapy

chemotherapy immune

immune checkpoint

checkpoint inhibitors

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!